RESTASIS 0.05% EYE EMULSION

cyclosporine
$10.3190per EA
High Outlier

Strength

.5 mg/mL

Manufacturer

Allergan, Inc.

NDC

00023916360

Classification

Brand

Dosage Form

EMULSION

Route

OPHTHALMIC

Last Updated

4/22/2026

Active Ingredients

CYCLOSPORINE

Approval Type

New Drug (NDA)

FDA Application

NDA050790

On Market Since

4/1/2003

Pharmacological Classes

Calcineurin Inhibitor Immunosuppressant
Calcineurin Inhibitors
Cytochrome P450 3A4 Inhibitors
P-Glycoprotein Inhibitors

Price History

1W

0.0%

1M

-0.0%

3M

-0.1%

6M

-0.1%

1Y

-0.1%

3Y

+0.0%

5Y

+4.9%

All

+115.2%